Table III.
Clinicopathological characteristics | Adjuvant chemotherapy | No adjuvant chemotherapy | P-value |
---|---|---|---|
Age (years), mean | 63.57 | 68.86 | 0.735 |
Sexa | |||
Male | 17 | 13 | 0.107 |
Female | 21 | 37 | |
eGFR (ml/min)a | |||
>60 | 15 | 8 | 0.025 |
<60 | 23 | 42 | |
Pathological stagea | |||
III | 30 | 43 | 0.558 |
IV | 8 | 7 | |
Gradea | |||
Low | 8 | 13 | 0.774 |
High | 30 | 37 | |
Lymphovascular invasiona | |||
No | 21 | 27 | 1.000 |
Yes | 17 | 23 | |
Perineural permeationa | |||
No | 30 | 38 | 0.944 |
Yes | 8 | 12 | |
Locationa | |||
Ureter | 13 | 15 | 0.850 |
Renal pelvis | 25 | 35 |
Data are presented as the number of patients. eGFR, estimated glomerular filtration rate.